Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-8-12
pubmed:abstractText
In clinically quiescent SLE hypergammaglobulinaemia, presence of autoantibodies, and increased soluble IL-2 receptors (sIL-2R) have been reported, suggesting persistent B as well as T cell activation. In contrast, the primary immune response to test antigens is markedly decreased. To analyse these phenomena at a cellular level, we undertook a cross-sectional study on 13 non-active SLE patients and 15 controls. We determined the composition of lymphocyte subsets with special attention to activation markers (CD25, HLA-DR, CD38) and the presence of naive T cells (CD45RO-), and related those findings to serological parameters. In non-active SLE patients the expression of activation markers on B cells and T cells was higher than in normal controls (P < or = 0.02), but was not interrelated. Percentages of activated B cells in SLE were related to levels of total IgG (P < 0.02) and IgM (P < 0.02) but not to anti-dsDNA, suggesting a disordered immune system also in clinically quiescent SLE. Numbers of CD4+ cells (P < 0.001) and CD4+CD45RO- cells (P < 0.05) were decreased. The latter finding might explain the anergy to primary test antigens in clinically quiescent SLE.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1395090, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1424281, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1540037, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1543196, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1599520, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1698987, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1896091, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-1975176, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2019007, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2142723, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2523219, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2646863, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2784457, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2950134, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2950862, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2963643, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2964961, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2970355, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-2974420, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-3257427, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-3264025, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-3829458, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-3872886, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-3930598, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-6192955, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-6603221, http://linkedlifedata.com/resource/pubmed/commentcorrection/8100746-7138600
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
39-44
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8100746-Adult, pubmed-meshheading:8100746-Antibodies, Antinuclear, pubmed-meshheading:8100746-Antigens, CD, pubmed-meshheading:8100746-Autoantibodies, pubmed-meshheading:8100746-B-Lymphocytes, pubmed-meshheading:8100746-CD4-Positive T-Lymphocytes, pubmed-meshheading:8100746-Cross-Sectional Studies, pubmed-meshheading:8100746-Female, pubmed-meshheading:8100746-Flow Cytometry, pubmed-meshheading:8100746-Humans, pubmed-meshheading:8100746-Hypergammaglobulinemia, pubmed-meshheading:8100746-Immunoglobulin G, pubmed-meshheading:8100746-Immunoglobulin M, pubmed-meshheading:8100746-Immunoglobulins, pubmed-meshheading:8100746-Lupus Erythematosus, Systemic, pubmed-meshheading:8100746-Lymphocyte Activation, pubmed-meshheading:8100746-Male, pubmed-meshheading:8100746-Middle Aged, pubmed-meshheading:8100746-T-Lymphocytes
pubmed:year
1993
pubmed:articleTitle
B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
pubmed:affiliation
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
pubmed:publicationType
Journal Article